Millendo Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced operating income was USD 10.160 million compared to USD 4.986 million a year ago. Net loss was USD 9.871 million compared to USD 4.846 million a year ago. Basic loss per share was USD 0.74 compared to USD 6.82 a year ago. For the half year, operating income was USD 20.817 million compared to USD 9.374 million a year ago. Net loss was USD 20.237 million compared to USD 9.107 million a year ago. Basic loss per share was USD 1.51 compared to USD 12.82 a year ago.